Xeomin® is a prescription medication used to effectively treat intramuscular conditions such as blepharospasm, or abnormal involuntary closing of the eyelid.
Xeomin® is composed of botulinum toxin type A, a naturally occurring protein that is produced by the bacteria Clostridium botulinum. Xeomin® is injected into the affected muscles in order to reduce their activity. Xeomin® does not stop the muscle from moving entirely; instead, it modifies the contractions. This is achieved by inhibiting a body chemical called acetylcholine from signaling all of the nerves within the muscle to contract.
Blepharospasm is a condition involving abnormal involuntary spasms of the eyelids. Injections of Xeomin® administered into the muscles of the eyelid can help relieve spasms for many patients.
The number of injections necessary will vary from patient to patient, depending upon the number of muscles affected and the severity of the condition. The results of treatment with Xeomin® are usually seen after one week and last, on the average, up to 12 weeks.
Risks Of Xeomin® Treatment
While an effective medication for muscle spasms, treatment with Xeomin® carries certain risks. Whether they occur hours or weeks after treatment, the following symptoms may be life-threatening and require urgent medical attention:
- Difficulty speaking, swallowing or breathing
- Muscle weakness throughout the body
- Double vision
- Blurred vision
- Drooping eyelids
- Change in voice quality
- Problems with articulation
- Loss of bladder control